Wealthstreet Investment Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-150
Closed -$9K 81
2021
Q2
$9K Sell
150
-17,724
-99% -$1.08M 0.05% 82
2021
Q1
$1.06M Buy
17,874
+189
+1% +$11.4K 0.1% 167
2020
Q4
$1.06M Sell
17,685
-3,210
-15% -$183K 0.11% 162
2020
Q3
$1.14M Buy
20,895
+435
+2% +$23.5K 0.13% 143
2020
Q2
$1.05M Buy
20,460
+9,375
+85% +$471K 0.13% 141
2020
Q1
$497K Buy
11,085
+3,585
+48% +$181K 0.07% 191
2019
Q4
$400K Hold
7,500
0.05% 252
2019
Q3
$366K Sell
7,500
-1,380
-16% -$66.1K 0.05% 255
2019
Q2
$446K Hold
8,880
0.06% 239
2019
Q1
$456K Sell
8,880
-30
-0.3% -$1.49K 0.06% 237
2018
Q4
$425K Sell
8,910
-6,000
-40% -$308K 0.06% 230
2018
Q3
$834K Sell
14,910
-465
-3% -$25.4K 0.1% 178
2018
Q2
$776K Buy
15,375
+90
+0.6% +$4.46K 0.1% 183
2018
Q1
$752K Buy
15,285
+4,218
+38% +$217K 0.09% 184
2017
Q4
$570K Buy
+11,067
New +$569K 0.07% 218

Other funds holding IHE

Wealthstreet Investment Advisors's IHE Position: Q3 2021 in Review

Wealthstreet Investment Advisors sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2021, closing a stake of 150 shares — an estimated $9K sold.

Wealthstreet Investment Advisors first reported a position in IHE in Q4 2017 and held it in 15 quarters. The position peaked at $1.14M in Q3 2020. 110 funds tracked by Wall St. Rank hold IHE as of Q3 2021.

  • Wealthstreet Investment Advisors reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2021 after selling out during the quarter.
  • Wealthstreet Investment Advisors sold 150 iShares US Pharmaceuticals ETF shares in Q3 2021, an estimated $9K.
  • Wealthstreet Investment Advisors first reported a position in iShares US Pharmaceuticals ETF in Q4 2017 and held it in 15 quarters.
  • Wealthstreet Investment Advisors's iShares US Pharmaceuticals ETF position peaked at $1.14M in Q3 2020.
  • 110 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2021.

Based on Wealthstreet Investment Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.